Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2019-10-17 2019-10-26 96730
TEVA-ZOLMITRIPTAN OD 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-13 2020-02-13 1674
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-10 2017-09-19 9805
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
TEVA-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-08-22 2019-09-19 92151
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-08-22 2019-11-21 92154
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
ACT ESCITALOPRAM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-02-21 99971
ACT ESCITALOPRAM ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-02-21 99974
TEVA-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-09-24 2020-10-30 124992
TEVA-ZOLMITRIPTAN OD 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-10-22 2020-11-26 126933
TEVA-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-02-18 2021-04-15 134340
ACT ESCITALOPRAM ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-04-29 2021-07-09 138282
TEVA-ZOLMITRIPTAN OD 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2021-09-30 2021-10-07 146472
ACT ESCITALOPRAM ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-03-24 2022-05-05 157265
ACT ESCITALOPRAM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2022-03-31 2022-06-17 157637

Showing 1 to 20 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-PIOGLITAZONE 15MG TABLET Discontinued 2018-10-19 2018-10-19 65026
TEVA-PIOGLITAZONE 30MG TABLET Discontinued 2018-10-19 2018-10-19 65030
TEVA-PIOGLITAZONE 45MG TABLET Discontinued 2018-10-19 2018-10-19 65033
TEVA-QUETIAPINE 100MG TABLET Discontinued 2018-10-19 2018-10-19 65036
TEVA-QUETIAPINE 200MG TABLET Discontinued 2018-10-19 2018-10-19 65039
TEVA-QUETIAPINE 25MG TABLET Discontinued 2018-10-19 2018-10-19 65044
TEVA-QUETIAPINE 300MG TABLET Discontinued 2018-10-19 2018-10-19 65047
ACT ZOPICLONE 5MG TABLET Discontinued 2018-10-22 2018-10-22 65191
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65213
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65218
ACT ETIDROCAL 400MG 500MG TABLET Discontinued 2019-02-21 2019-03-01 76486
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2019-04-11 2019-04-11 81298
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
TEVA-PAROXETINE 10MG TABLET Discontinued 2019-04-11 2019-04-11 81313
TEVA-NAPROXEN SODIUM DS 550MG TABLET Discontinued 2019-04-11 2019-04-11 81350
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Discontinued 2019-04-11 2019-04-11 81362
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368
TEVA-FAMOTIDINE 20MG TABLET Discontinued 2019-04-11 2019-04-11 81371
TEVA-PREDNISONE 5MG TABLET Discontinued 2019-04-11 2019-04-11 81376

Showing 61 to 80 of 250